Simona Skerjanec - 14 May 2024 Form 4 Insider Report for Avidity Biosciences, Inc. (RNA)

Role
Director
Signature
/s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact
Issuer symbol
RNA
Transactions as of
14 May 2024
Net transactions value
$0
Form type
4
Filing time
16 May 2024, 18:21:48 UTC
Next filing
24 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNA Stock Option (Right to Buy) Award $0 +42,308 $0.000000 42,308 14 May 2024 Common Stock 42,308 $28.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on May 14, 2024 and shall vest in substantially equal monthly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.